211 related articles for article (PubMed ID: 15295048)
21. Smad3 is essential for TGF-beta 1 to suppress IL-2 production and TCR-induced proliferation, but not IL-2-induced proliferation.
McKarns SC; Schwartz RH; Kaminski NE
J Immunol; 2004 Apr; 172(7):4275-84. PubMed ID: 15034041
[TBL] [Abstract][Full Text] [Related]
22. EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia.
Konantz M; André MC; Ebinger M; Grauer M; Wang H; Grzywna S; Rothfuss OC; Lehle S; Kustikova OS; Salih HR; Handgretinger R; Fend F; Baum C; Kanz L; Quintanilla-Martinez L; Schulze-Osthoff K; Essmann F; Lengerke C
Leukemia; 2013 Jan; 27(1):56-65. PubMed ID: 22828445
[TBL] [Abstract][Full Text] [Related]
23. The TGF-β-Smad3 pathway inhibits CD28-dependent cell growth and proliferation of CD4 T cells.
Delisle JS; Giroux M; Boucher G; Landry JR; Hardy MP; Lemieux S; Jones RG; Wilhelm BT; Perreault C
Genes Immun; 2013 Mar; 14(2):115-26. PubMed ID: 23328844
[TBL] [Abstract][Full Text] [Related]
24. Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia.
Jumaa H; Bossaller L; Portugal K; Storch B; Lotz M; Flemming A; Schrappe M; Postila V; Riikonen P; Pelkonen J; Niemeyer CM; Reth M
Nature; 2003 May; 423(6938):452-6. PubMed ID: 12761551
[TBL] [Abstract][Full Text] [Related]
25. ATM variants and predisposition to childhood T-lineage acute lymphoblastic leukaemia.
Gumy-Pause F; Wacker P; Maillet P; Betts DR; Sappino AP
Leukemia; 2006 Mar; 20(3):526-7; author reply 527. PubMed ID: 16408093
[No Abstract] [Full Text] [Related]
26. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1.
Nagel S; Scherr M; Kel A; Hornischer K; Crawford GE; Kaufmann M; Meyer C; Drexler HG; MacLeod RA
Cancer Res; 2007 Feb; 67(4):1461-71. PubMed ID: 17308084
[TBL] [Abstract][Full Text] [Related]
27. Mutational analysis of DOK2 tumor suppressor gene in acute leukemias.
Kim MS; Chung NG; Yoo NJ; Lee SH
Leuk Res; 2011 Jun; 35(6):e87-8. PubMed ID: 21329978
[No Abstract] [Full Text] [Related]
28. p27KIP1 deletions in childhood acute lymphoblastic leukemia.
Komuro H; Valentine MB; Rubnitz JE; Saito M; Raimondi SC; Carroll AJ; Yi T; Sherr CJ; Look AT
Neoplasia; 1999 Aug; 1(3):253-61. PubMed ID: 10935480
[TBL] [Abstract][Full Text] [Related]
29. Germline mutation of the p27/Kip1 gene in childhood acute lymphoblastic leukemia.
Takeuchi C; Takeuchi S; Ikezoe T; Bartram CR; Taguchi H; Koeffler HP
Leukemia; 2002 May; 16(5):956-8. PubMed ID: 11986963
[No Abstract] [Full Text] [Related]
30. Combined expression of pTalpha and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis.
Bellavia D; Campese AF; Checquolo S; Balestri A; Biondi A; Cazzaniga G; Lendahl U; Fehling HJ; Hayday AC; Frati L; von Boehmer H; Gulino A; Screpanti I
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3788-93. PubMed ID: 11891328
[TBL] [Abstract][Full Text] [Related]
31. Mutational analysis of Smad3, a candidate tumor suppressor implicated in TGF-beta and menin pathways, in parathyroid adenomas and enteropancreatic endocrine tumors.
Shattuck TM; Costa J; Bernstein M; Jensen RT; Chung DC; Arnold A
J Clin Endocrinol Metab; 2002 Aug; 87(8):3911-4. PubMed ID: 12161532
[TBL] [Abstract][Full Text] [Related]
32. Pathway-specific tumor suppression. Reduction of p27 accelerates gastrointestinal tumorigenesis in Apc mutant mice, but not in Smad3 mutant mice.
Philipp-Staheli J; Kim KH; Payne SR; Gurley KE; Liggitt D; Longton G; Kemp CJ
Cancer Cell; 2002 May; 1(4):355-68. PubMed ID: 12086850
[TBL] [Abstract][Full Text] [Related]
33. Monoallelic or biallelic LMO2 expression in relation to the LMO2 rearrangement status in pediatric T-cell acute lymphoblastic leukemia.
Van Vlierberghe P; Beverloo HB; Buijs-Gladdines J; van Wering ER; Horstmann M; Pieters R; Meijerink JP
Leukemia; 2008 Jul; 22(7):1434-7. PubMed ID: 18079736
[No Abstract] [Full Text] [Related]
34. EPHA7, a new target gene for 6q deletion in T-cell lymphoblastic lymphomas.
López-Nieva P; Vaquero C; Fernández-Navarro P; González-Sánchez L; Villa-Morales M; Santos J; Esteller M; Fernández-Piqueras J
Carcinogenesis; 2012 Feb; 33(2):452-8. PubMed ID: 22114070
[TBL] [Abstract][Full Text] [Related]
35. Decreased expression of transforming growth factor-beta II receptor is associated with that of p27KIP1 in giant cell tumor of bone: a possible link between transforming growth factor-beta and cell cycle-related protein.
Kawaguchi K; Oda Y; Saito T; Yamamoto H; Takahira T; Tamiya S; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2004 Jan; 35(1):61-8. PubMed ID: 14745726
[TBL] [Abstract][Full Text] [Related]
36. [Expression of P27(Kip1) and its clinical significance in acute and chronic leukemia].
Lu RN; Sheng RL; Li JY; Zhu GR; Ding XJ; Zhu LL; Su EB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Jun; 12(3):291-7. PubMed ID: 15228653
[TBL] [Abstract][Full Text] [Related]
37. Loss of CBP causes T cell lymphomagenesis in synergy with p27Kip1 insufficiency.
Kang-Decker N; Tong C; Boussouar F; Baker DJ; Xu W; Leontovich AA; Taylor WR; Brindle PK; van Deursen JM
Cancer Cell; 2004 Feb; 5(2):177-89. PubMed ID: 14998493
[TBL] [Abstract][Full Text] [Related]
38. Loss of heterozygosity in the chromosomal region 12p12-13 is very common in childhood acute lymphoblastic leukemia and permits the precise localization of a tumor-suppressor gene distinct from p27KIP1.
Cavé H; Gérard B; Martin E; Guidal C; Devaux I; Weissenbach J; Elion J; Vilmer E; Grandchamp B
Blood; 1995 Nov; 86(10):3869-75. PubMed ID: 7579355
[TBL] [Abstract][Full Text] [Related]
39. IL-7-dependent human leukemia T-cell line as a valuable tool for drug discovery in T-ALL.
Barata JT; Boussiotis VA; Yunes JA; Ferrando AA; Moreau LA; Veiga JP; Sallan SE; Look AT; Nadler LM; Cardoso AA
Blood; 2004 Mar; 103(5):1891-900. PubMed ID: 14615384
[TBL] [Abstract][Full Text] [Related]
40. Impairment in differentiation and cell cycle of thymocytes by loss of a Bcl11b tumor suppressor allele that contributes to leukemogenesis.
Go R; Takizawa K; Hirose S; Katsuragi Y; Aoyagi Y; Mishima Y; Kominami R
Leuk Res; 2012 Aug; 36(8):1035-40. PubMed ID: 22640496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
